Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1B1 | Q16678 | 7/20 | 1.00 |
| ▸ | CYP1A1 | P04798 | 6/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 6/20 | 1.00 |
| ▸ | MEN1 | O00255 | 5/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 5/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 1.00 |
| ▸ | MAPT | P10636 | 4/20 | 1.00 |
| ▸ | ABCC1 | P33527 | 3/20 | 1.00 |
| ▸ | POLB | P06746 | 2/20 | 1.00 |
| ▸ | IP6K2 | Q9UHH9 | 5/20 | 0.81 |
| ▸ | XDH | P47989 | 4/20 | 0.81 |
| ▸ | IPMK | Q8NFU5 | 4/20 | 0.81 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.81 |
| ▸ | KDM1A | O60341 | 1/20 | 0.81 |
| ▸ | MAOA | P21397 | 4/20 | 0.77 |
| ▸ | AKR1B1 | P15121 | 3/20 | 0.77 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.77 |
| ▸ | POLH | Q9Y253 | 3/20 | 0.73 |
| ▸ | LMNA | P02545 | 3/20 | 0.73 |
| ▸ | TP53 | P04637 | 3/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Chrysoeriol SCHEMBL29411724 | 1.00 | CYP1B1 (1.00) | CYP1B1CYP1A1CYP1A2MEN1KMT2A | |
| Chrysoeriol SCHEMBL30331803 | 1.00 | CYP1B1 (1.00) | CYP1B1CYP1A1CYP1A2MEN1KMT2A | |
| Chrysoeriol SCHEMBL17651838 | 0.93 | CYP1B1 (0.87) | CYP1B1CYP1A1CYP1A2MEN1KMT2A | |
| Velutin SCHEMBL5804380 | 0.92 | CYP1B1 (0.86) | CYP1B1CYP1A1CYP1A2MEN1KMT2A | |
| Velutin SCHEMBL29928535 | 0.92 | CYP1B1 (0.86) | CYP1B1CYP1A1CYP1A2MEN1KMT2A | |
| SCHEMBL29883103 | 0.92 | CYP1B1 (1.00) | CYP1B1CYP1A1CYP1A2MEN1KMT2A | |
| SCHEMBL30410973 | 0.92 | CYP1B1 (0.86) | CYP1B1CYP1A1CYP1A2MEN1KMT2A | |
| SCHEMBL2483636 | 0.92 | CYP1B1 (1.00) | CYP1B1CYP1A1CYP1A2MEN1KMT2A | |
| SCHEMBL30365934 | 0.92 | CYP1B1 (1.00) | CYP1B1CYP1A1CYP1A2MEN1KMT2A | |
| SCHEMBL4321016 | 0.92 | CYP1B1 (0.86) | CYP1B1CYP1A1CYP1A2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1246 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120330281-B | Highland barley flavonoid compound glycosyltransferase gene and application thereof | INSTITUTE OF AGRICULTURE, TIBET AUTONOMOUS REGION ACADEMY OF AGRICULTURE AND ANIMAL HUSBANDRY (CN) | 2026-05-26 | — | — | CN | claimed |
| US-20260077276-A1 | METHODS TO CONVERT THCA INTO THC | NATURAL EXTRACTION SYS LLC (US) | 2026-03-19 | — | — | US | claimed |
| EP-4698662-A2 | REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES | AskBio Inc. (US) | 2026-02-25 | — | — | EP | claimed |
| US-20250381166-A1 | Cannabis-Derived Flavonoids And Related Methods | CANURTA INC (CA) | 2025-12-18 | — | — | US | claimed |
| US-20250351836-A1 | SEED EXTRACT FOR USE DURING FOOD COOKING AND STORAGE PROCESSES | Khalifa University of Science and Technology (AE) | 2025-11-20 | — | — | US | claimed |
| WO-2025227265-A1 | METHODS FOR CONCENTRATING POLYPHENOLIC COMPOUNDS | CANURTA INC. (CA) | 2025-11-06 | — | — | WO | claimed |
| EP-2603098-B1 | METHOD OF IMPROVING STABILITY OF SWEET ENHANCER AND COMPOSITION CONTAINING STABILIZED SWEET ENHANCER | FIRMENICH INCORPORATED (US) | 2025-08-06 | — | — | EP | claimed |
| CN-120131696-A | Application of chrysoeriol alliance nofin in preparation of anti-melanoma medicine | 成都大学 | 2025-06-13 | — | — | CN | claimed |
| CN-116381117-B | Method for constructing map of snakegourd, allium macrostemon and pinellia tuber Shang Zhiwen and measuring content of index components | 澳门科技大学 | 2025-05-30 | — | — | CN | claimed |
| CN-120060043-A | Bacillus subtilis and application thereof | 内蒙古农业大学 | 2025-05-30 | — | — | CN | claimed |
| WO-2002049575-A2 | METHOD AND COMPOSITION FOR THE TREATMENT OF DIABETIC NEUROPATHY | THE QUIGLEY CORPORATION (US) | 2002-06-27 | — | — | WO | claimed |
| WO-2001051482-A1 | EXTRACTION OF FLAVONOIDS | BIOREX HEALTH LIMITED (AU) | 2001-07-19 | — | — | WO | claimed |
| US-6217875-B1 | ETHANOL EXTRACT OF PERILLA SEEDS | ORYZA OIL & FAT CHEMICAL CO., LTD. (JP) | 2001-04-17 | — | — | US | claimed |
| EP-1055408-A1 | Sorbate preserved compositions, process for their manufacture and their use | Nutrinova Nutrition Specialties & Food Ingredients GmbH (DE) | 2000-11-29 | — | — | EP | claimed |
| EP-0290442-A4 | PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS. | CHEMEX PHARMACEUTICALS INC (US) | 1990-07-03 | — | — | EP | claimed |
| EP-0290442-A1 | PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS | CHEMEX PHARMACEUTICALS, INC. (US) | 1988-11-17 | — | — | EP | claimed |
| US-4774229-A | ANTITUMOR AGENTS, SKIN DISORDERS, CANCER TREATMENT | CHEMEX PHARMACEUTICALS, INC. (US) | 1988-09-27 | — | — | US | claimed |
| WO-1988003805-A1 | PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS | CHEMEX PHARMACEUTICALS, INC. (US) | 1988-06-02 | — | — | WO | claimed |
| WO-1987006833-A1 | MODIFICATION OF PLANT EXTRACTS FROM ZYGOPHYLLACEAE | CHEMEX PHARMACEUTICALS, INC. (US) | 1987-11-19 | — | — | WO | claimed |
| US-4617293-A | Flavonoid phosphate salts of aminoglycoside antibiotics | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 1986-10-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260077276-A1 | METHODS TO CONVERT THCA INTO THC | CNR2, CNR1, FAAH | CYP1B1 267/4885CYP1A1 124/4885CYP1A2 99/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.